A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance A Alkrekchi, W Wang, PS Rana, V Markovic, K Sossey-Alaoui Cellular Signalling, 110073, 2021 | 46 | 2021 |
Calibration and characterization of intracellular Asante Potassium Green probes, APG-2 and APG-4 PS Rana, BA Gibbons, AA Vereninov, VE Yurinskaya, RJ Clements, ... Analytical biochemistry 567, 8-13, 2019 | 24 | 2019 |
Calibrated brightfield‐based imaging for measuring intracellular protein concentration NJ Mudrak, PS Rana, MA Model Cytometry Part A 93 (3), 297-304, 2018 | 24 | 2018 |
Evidence for macromolecular crowding as a direct apoptotic stimulus PS Rana, M Kurokawa, MA Model Journal of cell science 133 (9), jcs243931, 2020 | 18 | 2020 |
The role of WAVE2 signaling in cancer PS Rana, A Alkrekshi, W Wang, V Markovic, K Sossey-Alaoui Biomedicines 9 (9), 1217, 2021 | 16 | 2021 |
Staurosporine-induced apoptotic water loss is cell-and attachment-specific MA Model, NJ Mudrak, PS Rana, RJ Clements Apoptosis 23, 449-455, 2018 | 13 | 2018 |
A reverse-osmosis model of apoptotic shrinkage PS Rana, MA Model Frontiers in cell and developmental biology 8, 588721, 2020 | 9 | 2020 |
Phase separation in necrotic cells PS Rana, NJ Mudrak, R Lopez, M Lynn, L Kershner, MA Model Biochemical and biophysical research communications 492 (3), 300-303, 2017 | 9 | 2017 |
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction PS Rana, DC Soler, J Kort, JJ Driscoll Frontiers in Cell and Developmental Biology 10, 1059715, 2022 | 8 | 2022 |
Targeted deletion of kindlin-2 in mouse mammary glands inhibits tumor growth, invasion, and metastasis downstream of a TGF-β/EGF oncogenic signaling pathway W Wang, PS Rana, A Alkrekshi, K Bialkowska, V Markovic, ... Cancers 14 (3), 639, 2022 | 7 | 2022 |
Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma E Malek, PS Rana, M Swamydas, M Daunov, M Miyagi, E Murphy, ... Research Square, 2023 | 6 | 2023 |
Road testing new CAR design strategies in multiple myeloma PS Rana, EV Murphy, J Kort, JJ Driscoll Frontiers in Immunology 13, 957157, 2022 | 6 | 2022 |
YB1 is a major contributor to health disparities in triple negative breast cancer PS Rana, W Wang, A Alkrekshi, V Markovic, A Khiyami, R Chan, ... Cancers 13 (24), 6262, 2021 | 6 | 2021 |
The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer W Wang, PS Rana, V Markovic, K Sossey-Alaoui Breast Cancer Research 25 (1), 31, 2023 | 3 | 2023 |
The WAVE2/miR-29/integrin-β1 oncogenic signaling axis promotes tumor growth and metastasis in triple-negative breast cancer PS Rana, W Wang, V Markovic, J Szpendyk, ER Chan, K Sossey-Alaoui Cancer Research Communications 3 (1), 160-174, 2023 | 3 | 2023 |
Current and emerging strategies to treat urothelial carcinoma B Rani, JJ Ignatz-Hoover, PS Rana, JJ Driscoll Cancers 15 (19), 4886, 2023 | 2 | 2023 |
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer F Quaglia, SR Krishn, K Sossey-Alaoui, PS Rana, E Pluskota, PH Park, ... Scientific Reports 12 (1), 18879, 2022 | 2 | 2022 |
Abstract P1-06-02: Targeted deletion of Kindlin-2 in mouse mammary glands inhibits tumor growth, invasion and metastasis downstream of TGF-β/EGF oncogenic signaling pathway P Rana, W Wang, A Alkrekchi, K Bialkowska, V Markovic, EF Plow, ... Cancer Research 82 (4_Supplement), P1-06-02-P1-06-02, 2022 | 2 | 2022 |
Vactosertib, a novel TGF-β type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma J Driscoll, E Malek, P Rana, M Swamydas, M Daunov, M Miyagi, ... | 1 | 2023 |
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma PS Rana, K Goparaju, JJ Driscoll Frontiers in Oncology 13, 1141851, 2023 | 1 | 2023 |